Jupiter Neurosciences (JUNS) Share-based Compensation (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Share-based Compensation for 4 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 84.55% year-over-year to $1.7 million in Q2 2026; TTM through Jun 2026 was $1.7 million, a 84.55% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 77.26% from the prior year.
• Share-based Compensation was $1.7 million for Q2 2026 at Jupiter Neurosciences, up from $463241.0 in the prior quarter.
• Over five years, Share-based Compensation peaked at $11.7 million in Q3 2025 and troughed at $60000.0 in Q1 2024.
• A 4-year average of $4.8 million and a median of $1.3 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation soared 17623.31% in 2025 and plunged 84.55% in 2026, its largest moves.
• Over 4 years, Share-based Compensation stood at $213203.0 in 2023, then surged by 375.39% to $1.0 million in 2024, then sank by 54.3% to $463241.0 in 2025, then jumped by 263.09% to $1.7 million in 2026.
• The last three Share-based Compensation figures came in at $1.7 million (Q2 2026), $463241.0 (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.